Presented by Cello Health BioConsulting, now part of Lumanity


  • Navneet K. Bhogal, PhD, Senior Analyst –Checkpoints at Beacon Targeted Therapies
  • Sam Fieldwick, Commercial Manager at Beacon Targeted Therapies


  • Jeffery Bockman, PhD, Executive VP, Head of Oncology Practice
  • Michael A. Curran, PhD, Associate Professor of Immunology at MD Anderson Cancer Center
  • Emmett Schimdt, MD, Associate Vice President, Merck